Guotai Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Guotai Li has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Qihui Zhou
Shandong Key Laboratory of Neurorehabilitation, Shandong Engineering Research Center for Tissue Rehabilitation Materials and Devices, Department of Traditional Chinese Medicine (Qingdao Central Hospital), Department of Hematology (Qingdao Central Hospital), School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266113, China
5 shared publications Muhammad Arif
Department of Orthopedic Surgery, Qingdao Municipal Hospital, Shandong Engineering Research Center for Tissue Rehabilitation Materials and Devices, Qingdao Key Laboratory of Smart Rehabilitation Material, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266113, China
2 shared publicationsBingcheng Fan
College of Medicine, Qingdao University , Qingdao 266071
1 shared publicationBingqiang Zhang
Key Laboratory of Cancer and Immune Cells of Qingdao, Qingdao 266111, China
1 shared publicationChunli Ma
Qingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, Shandong Engineering Research Center for Tissue Rehabilitation Materials and Devices, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao 266113, China; Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
1 shared publicationChunyan Wan
Department of Stomatology, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao 266003, China; School of Stomatology, Qingdao University, Qingdao 266003, China
1 shared publication
Latest Publications
- 13 April 2026
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 718, 140494
Targeted catalytic eradication of antibiotic-resistant Helicobacter pylori by a pH-activated Fe-doped nanozyme
- 13 April 2026
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 718, 140494
Targeted catalytic eradication of antibiotic-resistant Helicobacter pylori by a pH-activated Fe-doped nanozyme
- Open Access
- 28 January 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115473
Intraocular-microenvironment responsive fluorescent hydrogels in rhegmatogenous retinal detachment repair
- 28 January 2026
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 262, 115473
Open AccessIntraocular-microenvironment responsive fluorescent hydrogels in rhegmatogenous retinal detachment repair
- Open Access
- 22 January 2026
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 13
Dual-mode rapid hemostatic materials composed of gelatin and carboxymethyl cellulose for non-compressible bleeding in spinal surgery
Spinal surgery, particularly spinal decompression and fusion surgery, commonly encounters intraoperative bleeding. Deep bleeding in the narrow operative area (e.g. bone marrow cavity and venous plexus) is a significant challenge for achieving accurate hemostasis with traditional strategies, posing a life-threatening risk. Herein, a novel dual-form hemostatic material (CMC-Gelatin, CG) composed of carboxymethyl cellulose (CMC) and gelatin is developed for non-compressible hemostasis in spinal surgery. For minor bleeding, CG in powder form reduces blood loss by 69.06% within a mouse bleeding model, demonstrating hemostatic efficacy comparable to that of the commercial Surgicel® powder, while exhibiting superior cytocompatibility. Notably, CG powder rapidly forms an injectable gel upon mixing with saline, making it suitable for severe bleeding in a confined space during spinal surgery. Specifically, in a pig paraspinal microvenous hemorrhage model, CG gel exhibits excellent hemostatic performance, reducing blood loss by 78.44% compared with the untreated group. Importantly, CG demonstrated a comparable hemostasis time and reduced blood loss in vivo compared to the commercial Surgiflo®. The designed CG materials exhibit outstanding hemostatic properties in deep, narrow areas, making them a promising hemostatic material in spinal surgery.
- 22 January 2026
- Published by Oxford University Press (OUP) in Regenerative Biomaterials
- Vol. 13
Open AccessDual-mode rapid hemostatic materials composed of gelatin and carboxymethyl cellulose for non-compressible bleeding in spinal surgery
Spinal surgery, particularly spinal decompression and fusion surgery, commonly encounters intraoperative bleeding. Deep bleeding in the narrow operative area (e.g. bone marrow cavity and venous plexus) is a significant challenge for achieving accurate hemostasis with traditional strategies, posing a life-threatening risk. Herein, a novel dual-form hemostatic material (CMC-Gelatin, CG) composed of carboxymethyl cellulose (CMC) and gelatin is developed for non-compressible hemostasis in spinal surgery. For minor bleeding, CG in powder form reduces blood loss by 69.06% within a mouse bleeding model, demonstrating hemostatic efficacy comparable to that of the commercial Surgicel® powder, while exhibiting superior cytocompatibility. Notably, CG powder rapidly forms an injectable gel upon mixing with saline, making it suitable for severe bleeding in a confined space during spinal surgery. Specifically, in a pig paraspinal microvenous hemorrhage model, CG gel exhibits excellent hemostatic performance, reducing blood loss by 78.44% compared with the untreated group. Importantly, CG demonstrated a comparable hemostasis time and reduced blood loss in vivo compared to the commercial Surgiflo®. The designed CG materials exhibit outstanding hemostatic properties in deep, narrow areas, making them a promising hemostatic material in spinal surgery.
- 17 June 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 255, 114893
Keratin and hyaluronic acid-based microneedle patches with hop extract: An alternative strategy in oral ulcer treatment
- 17 June 2025
- Published by Elsevier in Colloids and Surfaces B: Biointerfaces
- Vol. 255, 114893
Keratin and hyaluronic acid-based microneedle patches with hop extract: An alternative strategy in oral ulcer treatment